HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juergen C Becker Selected Research

N- (5- (3- dimethylaminobenzamido)- 2- methylphenyl)- 4- hydroxybenzamide

9/2007Activation of the MAP kinase pathway induces apoptosis in the Merkel cell carcinoma cell line UISO.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Juergen C Becker Research Topics

Disease

13Neoplasms (Cancer)
01/2021 - 01/2005
9Melanoma (Melanoma, Malignant)
03/2016 - 02/2006
6Merkel Cell Carcinoma
03/2022 - 05/2006
3Neoplasm Metastasis (Metastasis)
03/2022 - 10/2006
3Disease Progression
11/2010 - 07/2007
2Lymphatic Metastasis
07/2007 - 02/2006
1Brain Neoplasms (Brain Tumor)
03/2016
1Skin Neoplasms (Skin Cancer)
04/2011
1Infections
11/2010
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
06/2009
1Necrosis
07/2007
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2006

Drug/Important Bio-Agent (IBA)

4Phosphotransferases (Kinase)IBA
06/2009 - 05/2006
3SurvivinIBA
02/2009 - 01/2005
2AntigensIBA
07/2013 - 10/2006
2Proteins (Proteins, Gene)FDA Link
07/2013 - 07/2007
2Biomarkers (Surrogate Marker)IBA
04/2011 - 02/2006
2Indicators and Reagents (Reagents)IBA
11/2010 - 08/2008
2EpitopesIBA
08/2009 - 10/2006
2Peptides (Polypeptides)IBA
08/2009 - 10/2006
1avelumabIBA
03/2022
1IpilimumabIBA
03/2022
1NivolumabIBA
03/2022
1Immune Checkpoint InhibitorsIBA
03/2022
1Radioisotopes (Radionuclides)IBA
03/2022
1Peptide Receptors (Peptide Receptor)IBA
03/2022
1SuspensionsIBA
01/2021
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2016
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
07/2013
1Threonine (L-Threonine)FDA Link
01/2012
1Biological ProductsIBA
04/2011
1Oncogene Proteins (Oncogene Protein)IBA
11/2010
1AntibodiesIBA
11/2010
1Tumor Viral Antigens (Large T Antigen)IBA
11/2010
1NF-kappa B (NF-kB)IBA
06/2009
1Sorafenib (BAY 43-9006)FDA Link
02/2009
1Phosphatidylethanolamine Binding ProteinIBA
08/2008
1Mitogen-Activated Protein KinasesIBA
08/2008
1Toll-Like Receptor 7IBA
02/2008
1N- (5- (3- dimethylaminobenzamido)- 2- methylphenyl)- 4- hydroxybenzamideIBA
09/2007
1Interleukin-1beta (Interleukin 1 beta)IBA
07/2007
1RNA (Ribonucleic Acid)IBA
07/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2007
1Dinoprostone (PGE2)FDA Link
07/2007
1Interleukin-6 (Interleukin 6)IBA
07/2007
1ChemokinesIBA
07/2007
1Chemokine ReceptorsIBA
07/2007
1Matrix Metalloproteinases (MMPs)IBA
07/2007
1Monatide (IMS 3015)IBA
10/2006
1HLA-A1 Antigen (HLA A1 Antigen)IBA
10/2006
1HLA-A2 Antigen (HLA A2 Antigen)IBA
10/2006
1GemcitabineFDA Link
10/2006
1Neoplasm Antigens (Tumor Antigens)IBA
10/2006
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
02/2006
1A-Form DNA (A-DNA)IBA
01/2005
1DNA VaccinesIBA
01/2005
1VaccinesIBA
01/2005
1Inhibitor of Apoptosis ProteinsIBA
01/2005
1Chemokine CCL21IBA
01/2005

Therapy/Procedure

4Therapeutics
03/2022 - 10/2006
4Immunotherapy
03/2022 - 10/2006
1Radiotherapy
03/2022
1Drug Therapy (Chemotherapy)
02/2008